Condition (MeSH)
Cyanosis
ClinicalTrials.gov lists 9 trials for Cyanosis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 9 trials are tagged with Cyanosis itself; the rest are tagged with a narrower condition beneath it.
When did Cyanosis trials start? (6)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2021 | 2 |
| 2018 | 1 |
| 2017 | 2 |
| 2016 | 1 |
| 2009 | 1 |
| 2006 | 2 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Cyanosis trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Not applicable | 4 |
| Observational | 3 |
How many Cyanosis trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Completed | 2 |
| Terminated | 5 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Cyanosis? (47)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Evaluation of the effectiveness of valproic acid for treating cyanotic breath holding spells: A Pilot prospective study. | Expert review of clinical pharmacology | 2020 | Yes |
| Perinatal cyanosis: long-term cognitive sequelae and behavioral consequences. | Applied neuropsychology. Child | 2012 | Yes |
| Intestinal microbiota and blue baby syndrome: probiotic therapy for term neonates with cyanotic congenital heart disease. | Gut microbes | 2010 | Yes |
| Prevalence of iron deficiency in children with cyanotic heart disease seen at Kenyatta National Hospital and Mater Hospital Nairobi. | East African medical journal | 2009 | Yes |
| Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis | 2008 | Yes |
Showing 5 of 47 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, and rare-disease identity.
Not computed for conditions with fewer than 10 trials: drugs tested.